speb/financial-data huggingface dataset:
Financial ratios for BMA — quarterly report dated 2024-09-30
Total revenue: 1110273221.0726898
Net income: 124607544.45376498
Capital expenditures: 45844232.143411934
Operating cash flow: 2546672435.041062
Depreciation & amortization: 46568295.68873562
Net tangible assets: 3625972850.322594
Owner earnings: 125331607.99908864
Return on net tangible assets (%): 3.4564960404471363
Buffett classification: The Gruesome
Stock price: 61.21
P/E ratio: 7.714088474909006
Shares outstanding: 62815463
Book value: 3772495733.2670536
P/B ratio: 1.0192018128275557
Market cap (USD): 3844934490.23
Debt to equity: 0.13139583197942045
Effective tax rate (%): 24.431006681479424
COGS to revenue (%): 0
SG&A to revenue (%): 29.474533048584473
Free cash flow (dilution-adjusted): 2500828202.8976502
Buyback yield (%): 0
Retained earnings: 203353429.43838608
Receivables turnover: 1.0282306169790787
Capitalized R&D asset: 0
FCF margin (%): 225.24439529231165
Rule of 40 score: 225.24439529231165
Financial ratios for BMA — quarterly report dated 2024-12-31
Total revenue: 1054116656.9671575
Net income: 126852897.24339949
Capital expenditures: 37017694.81464238
Operating cash flow: -492286252.88560396
Depreciation & amortization: 43623918.0197482
Net tangible assets: 4978288494.442182
Owner earnings: 133459120.44850531
Return on net tangible assets (%): 2.6808233511878754
Buffett classification: The Gruesome
Stock price: 93.27
P/E ratio: 11.546441510847814
Shares outstanding: 62815463
Book value: 5168540818.444588
P/B ratio: 1.1335497657486115
Market cap (USD): 5858798234.009999
Debt to equity: 0.11021612395831552
Effective tax rate (%): 22.255209780682055
COGS to revenue (%): 0
SG&A to revenue (%): 28.469765960577508
Free cash flow (dilution-adjusted): -529303947.70024633
Buyback yield (%): 0
Retained earnings: -665584588.4498245
Receivables turnover: 0.7980185821536504
Capitalized R&D asset: 0
FCF margin (%): -50.213033273103626
Revenue growth (%): -5.057904940846602
Rule of 40 score: -55.27093821395023
Financial ratios for BMA — annual report dated 2024-12-31
Total revenue: 5771030829.890007
Net income: 416589227.7250771
Capital expenditures: 158877614.50270617
Operating cash flow: 2554645158.974956
Depreciation & amortization: 176261537.56619915
Net tangible assets: 4978288494.442182
Owner earnings: 433973150.78857005
Return on net tangible assets (%): 8.717316227716868
Buffett classification: The Gruesome
Stock price: 93.27
P/E ratio: 14.06372955441959
Shares outstanding: 62815463
Book value: 5168540818.444588
P/B ratio: 1.1335497657486115
Market cap (USD): 5858798234.009999
Debt to equity: 0.11021612395831552
Effective tax rate (%): 9.311673932745059
COGS to revenue (%): 0
SG&A to revenue (%): 23.09327351932928
Free cash flow (dilution-adjusted): 2395767544.4722495
Buyback yield (%): 0
Retained earnings: -665584588.4498245
Receivables turnover: 4.368956519180889
Capitalized R&D asset: 0
FCF margin (%): 41.51368473139679
Revenue growth (%): -42.29310190609115
Rule of 40 score: -0.779417174694359
Financial ratios for BMA — quarterly report dated 2025-03-31
Total revenue: 1008400210.1234475
Net income: 56846977.59933961
Capital expenditures: 45152023.37623354
Operating cash flow: -536523573.2242693
Depreciation & amortization: 46141389.62890699
Net tangible assets: 4013175447.4503775
Owner earnings: 57836343.85201306
Return on net tangible assets (%): 1.4411616090384796
Buffett classification: The Gruesome
Stock price: 72.79
P/E ratio: 20.108094329992653
Shares outstanding: 62815463
Book value: 4167041410.2660313
P/B ratio: 1.0972623263367316
Market cap (USD): 4572337551.77
Debt to equity: 0.10676103610125388
Effective tax rate (%): 42.98463442527223
COGS to revenue (%): 0
SG&A to revenue (%): 31.55133462207116
Free cash flow (dilution-adjusted): -581675596.6005028
Buyback yield (%): 0
Retained earnings: 361975484.9724213
Receivables turnover: 2.1556578169660425
Capitalized R&D asset: 0
FCF margin (%): -57.683010253369005
Revenue growth (%): -4.336943785258325
Rule of 40 score: -62.01995403862733
Financial ratios for BMA — quarterly report dated 2025-06-30
Total revenue: 857163998.5512495
Net income: 125957441.27085738
Capital expenditures: 21786408.69924109
Operating cash flow: -279549306.3686059
Depreciation & amortization: 33002046.781162873
Net tangible assets: 3662092308.9881487
Owner earnings: 137173079.35277915
Return on net tangible assets (%): 3.745757009349681
Buffett classification: The Gruesome
Stock price: 67.68
P/E ratio: 9.789764086105576
Shares outstanding: 62815463
Book value: 3806051803.7785435
P/B ratio: 1.1169975489086554
Market cap (USD): 4251350535.8400006
Debt to equity: 0.21753132299896158
Effective tax rate (%): 39.04308051809507
COGS to revenue (%): 0
SG&A to revenue (%): 26.62141249955311
Free cash flow (dilution-adjusted): -301335715.067847
Buyback yield (%): 0
Retained earnings: 166363069.4979069
Receivables turnover: 1.8895803787987218
Capitalized R&D asset: 0
FCF margin (%): -35.154966328165294
Revenue growth (%): -14.997637847941721
Rule of 40 score: -50.15260417610702
Financial ratios for BMA — quarterly report dated 2025-09-30
Total revenue: 641012488.8623796
Net income: -24348343.53208003
Capital expenditures: 33280017.820192784
Operating cash flow: 379733895.9212377
Depreciation & amortization: 34219977.761577606
Net tangible assets: 3375266064.314696
Owner earnings: -23408383.590695206
Return on net tangible assets (%): -0.6935270625975963
Buffett classification: The Gruesome
Stock price: 41.01
P/E ratio: 9.029026021584322
Shares outstanding: 62815463
Book value: 3505115815.052908
P/B ratio: 0.7349435150093936
Market cap (USD): 2576062137.6299996
Debt to equity: 0.2742728037707959
COGS to revenue (%): 0
SG&A to revenue (%): 37.12048391147276
Free cash flow (dilution-adjusted): 346453878.1010449
Buyback yield (%): 0
Retained earnings: 129750432.6183165
Receivables turnover: 1.3628601778783518
Capitalized R&D asset: 0
FCF margin (%): 54.047913905063695
Revenue growth (%): -25.21705415232116
Rule of 40 score: 28.830859752742533
Financial ratios for BMA — quarterly report dated 2025-12-31
Total revenue: 1032547672.391818
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 87.44
P/E ratio: 34.66313344565556
Shares outstanding: 62815463
Market cap (USD): 5492584084.72
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 61.080741847059095
Rule of 40 score: 61.080741847059095
Financial ratios for BMA — annual report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 87.44
Shares outstanding: 62815463
Market cap (USD): 5492584084.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CASP.L — annual report dated 2021-12-31
Total revenue: 33778378.37837838
Gross profit: 26178378.37837838
Operating income: 11435135.135135135
Net income: -7494594.594594595
Capital expenditures: 10614864.864864865
Net tangible assets: 69518918.91891892
Owner earnings: -18109459.45945946
Return on net tangible assets (%): -26.04968509447166
Capex to operating income (%): 92.82675490427795
Buffett classification: The Gruesome
Stock price: 0.0006756756756756757
Shares outstanding: 2356306042
Book value: 61679729.72972974
P/B ratio: 0.025812348465263014
Market cap (USD): 1592098.6770270271
Debt to equity: 0.14076638257783228
Current ratio: 0.2133451015004413
Quick ratio: 0.18990291262135922
Interest coverage ratio: 9.850989522700814
COGS to revenue (%): 22.49959993598976
SG&A to revenue (%): 43.646983517362784
Free cash flow (dilution-adjusted): -144594.5945945946
Buyback yield (%): 0
Retained earnings: -211133783.7837838
Inventory turnover: 8.46987951807229
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.852595300747502
FCF margin (%): -0.42806849095855337
Rule of 40 score: -0.42806849095855337
Financial ratios for CASP.L — annual report dated 2022-12-31
Total revenue: 49268674.698795184
Gross profit: 38765060.240963854
Operating income: 15503614.457831327
Net income: 12013253.012048194
Capital expenditures: 14424096.38554217
Net tangible assets: 72855421.68674698
Owner earnings: -2410843.373493975
Return on net tangible assets (%): -3.309078882090292
Capex to operating income (%): 93.0369909853901
Buffett classification: The Gruesome
Stock price: 0.0004819277108433735
P/E ratio: 0.09452636814762812
Shares outstanding: 2356306042
Book value: 66027710.84337351
P/B ratio: 0.017198372658431105
Market cap (USD): 1135569.17686747
Debt to equity: 0.006423006039815338
Current ratio: 0.3719310397906565
Quick ratio: 0.3529977680289387
Effective tax rate (%): 19.21082482579809
Interest coverage ratio: 21.996581196581197
COGS to revenue (%): 21.319052160516467
SG&A to revenue (%): 47.72944024649696
Free cash flow (dilution-adjusted): 7686746.987951808
Buyback yield (%): 0
Retained earnings: 102138554.21686748
Inventory turnover: 17.71951219512195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.035317343455164
FCF margin (%): 15.601692221162548
Revenue growth (%): 45.858614486751634
Rule of 40 score: 61.460306707914185
Financial ratios for CASP.L — annual report dated 2023-12-31
Total revenue: 19032911.392405063
Gross profit: 5313924.050632911
Operating income: -7594.936708860759
Net income: 14056962.025316454
Capital expenditures: 15470886.075949367
Net tangible assets: 90456962.02531645
Owner earnings: -1413924.0506329127
Return on net tangible assets (%): -1.5630903569779337
Buffett classification: The Gruesome
Stock price: 0.0003797468354430379
P/E ratio: 0.06365527353444395
Shares outstanding: 2356306042
Book value: 83935443.03797467
P/B ratio: 0.010660571153237118
Market cap (USD): 894799.76278481
Debt to equity: 0.10095160536277129
Current ratio: 0.4968096732118306
Quick ratio: 0.44403708534564806
Interest coverage ratio: -0.015037593984962405
COGS to revenue (%): 72.08034051609471
SG&A to revenue (%): 53.05932428837457
Free cash flow (dilution-adjusted): -8305063.29113924
Buyback yield (%): 0
Retained earnings: 114716455.69620253
Inventory turnover: 7.239812959251838
Receivables turnover: 4.059395248380129
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.005630894843038806
FCF margin (%): -43.63527533918595
Revenue growth (%): -61.36914274889052
Rule of 40 score: -105.00441808807648
Financial ratios for CASP.L — annual report dated 2024-12-31
Total revenue: 39337500
Gross profit: 11561250
Operating income: 6393750
Net income: 20988750
Capital expenditures: 19857500
Net tangible assets: 96202500
Owner earnings: 1131250
Return on net tangible assets (%): 1.1759049920740106
Capex to operating income (%): 310.57673509286417
Buffett classification: The Gruesome
Stock price: 0.00037499999999999995
P/E ratio: 0.04209944688225835
Shares outstanding: 2356306042
Book value: 88113750
P/B ratio: 0.010028114406094394
Market cap (USD): 883614.7657499999
Debt to equity: 0.07813763459165
Current ratio: 1.7959381044487428
Quick ratio: 1.7212167265358755
Effective tax rate (%): -40.163778327937536
Interest coverage ratio: 14.013698630136986
COGS to revenue (%): 70.61010486177311
SG&A to revenue (%): 13.136320305052433
Free cash flow (dilution-adjusted): 2480000
Buyback yield (%): 0
Retained earnings: 134050000
Inventory turnover: 6.847765793528505
Receivables turnover: 8.19104633003644
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.5758434621464
FCF margin (%): 6.304416904988878
Revenue growth (%): 106.68146448523544
Rule of 40 score: 112.98588139022432
Financial ratios for CASP.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 96202500
Buffett classification: The Gruesome
Stock price: 0.00037499999999999995
Shares outstanding: 2356306042
Book value: 88113750
P/B ratio: 0.010028114406094394
Market cap (USD): 883614.7657499999
Debt to equity: 0.07813763459165
Current ratio: 1.7959381044487428
Quick ratio: 1.7212167265358755
Buyback yield (%): 0
Retained earnings: 134050000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFHS.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.20567567567567568
Shares outstanding: 1466921000
Market cap (USD): 301709967.8378379
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFHS.L — annual report dated 2022-12-31
Total revenue: 457696274698.7952
Net income: 45737486746.98795
Capital expenditures: 4800873493.9759035
Operating cash flow: -31632415662.650604
Depreciation & amortization: 9089233734.93976
Net tangible assets: 659281593975.9037
Owner earnings: 50025846987.951805
Return on net tangible assets (%): 7.587933205637198
Buffett classification: The Gruesome
Stock price: 0.19530120481927715
P/E ratio: 0.006263821190252999
Shares outstanding: 1466921000
Book value: 736997632530.1211
P/B ratio: 0.0003887277598045608
Market cap (USD): 286491438.6746988
Debt to equity: 0.3891267571791824
Effective tax rate (%): 23.99641209365171
COGS to revenue (%): 0
SG&A to revenue (%): 7.123630268326414
Free cash flow (dilution-adjusted): -38380590361.445786
Buyback yield (%): 0
Retained earnings: 277508146987.95184
Receivables turnover: 1.749400572920906
Capitalized R&D asset: 0
FCF margin (%): -8.385602523573874
Rule of 40 score: -8.385602523573874
Financial ratios for CFHS.L — annual report dated 2023-12-31
Total revenue: 335730694936.70886
Net income: 65207363291.13924
Capital expenditures: 5739220253.1645565
Operating cash flow: -74999489873.41772
Depreciation & amortization: 10931596202.531645
Net tangible assets: 934664520253.1646
Owner earnings: 70399739240.50633
Return on net tangible assets (%): 7.5320864026632535
Buffett classification: The Gruesome
Stock price: 0.20810126582278482
P/E ratio: 0.004681497633926059
Shares outstanding: 1466921000
Book value: 1014488167088.6074
P/B ratio: 0.0003009085042737247
Market cap (USD): 305268116.96202534
Debt to equity: 0.3562163177098377
Effective tax rate (%): 11.360739679035207
COGS to revenue (%): 0
SG&A to revenue (%): 12.218047399797898
Free cash flow (dilution-adjusted): -81578017721.51898
Buyback yield (%): 0
Retained earnings: 63595516455.6962
Receivables turnover: 1.0683516851079313
Capitalized R&D asset: 0
FCF margin (%): -24.298647383700757
Revenue growth (%): -26.64771083014616
Rule of 40 score: -50.94635821384692
Financial ratios for CFHS.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.22626666666666664
Shares outstanding: 1466921000
Market cap (USD): 331915324.9333333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFHS.L — quarterly report dated 2024-12-31
Total revenue: 71249400000
Net income: 9840527500
Capital expenditures: 2282347500
Operating cash flow: -211204796250
Depreciation & amortization: 2688347500
Net tangible assets: 1069423930000
Owner earnings: 10246527500
Return on net tangible assets (%): 0.9581352364164882
Buffett classification: The Gruesome
Stock price: 0.21212499999999998
P/E ratio: 0.007905333761960422
Shares outstanding: 1466921000
Book value: 1133158381250
P/B ratio: 0.0002746046998141108
Market cap (USD): 311170617.125
Debt to equity: 0.4416821896052141
Effective tax rate (%): -35.97269499601707
COGS to revenue (%): 0
SG&A to revenue (%): 19.452812935968584
Free cash flow (dilution-adjusted): -213916530000
Buyback yield (%): 0
Retained earnings: 341712996250
Receivables turnover: 0.1857758783863052
Capitalized R&D asset: 0
FCF margin (%): -300.2362546210915
Rule of 40 score: -300.2362546210915
Financial ratios for CFHS.L — annual report dated 2024-12-31
Total revenue: 451164632500
Net income: 139033647500
Capital expenditures: 6026756250
Operating cash flow: -115177576250
Depreciation & amortization: 10544892500
Net tangible assets: 1069423930000
Owner earnings: 143551783750
Return on net tangible assets (%): 13.423281424981765
Buffett classification: The Gruesome
Stock price: 0.21212499999999998
P/E ratio: 0.0022380957611358066
Shares outstanding: 1466921000
Book value: 1133158381250
P/B ratio: 0.0002746046998141108
Market cap (USD): 311170617.125
Debt to equity: 0.4416821896052141
Effective tax rate (%): 13.107411613694453
COGS to revenue (%): 0
SG&A to revenue (%): 10.278808811548409
Free cash flow (dilution-adjusted): -122601365000
Buyback yield (%): 0
Retained earnings: 341712996250
Receivables turnover: 1.1763678837930154
Capitalized R&D asset: 0
FCF margin (%): -27.17441842030913
Revenue growth (%): 34.38289656090351
Rule of 40 score: 7.20847814059438
Financial ratios for CFHS.L — quarterly report dated 2025-03-31
Total revenue: 150926358441.55844
Net income: 41837215584.41558
Capital expenditures: 1516677922.077922
Operating cash flow: -37478233766.233765
Depreciation & amortization: 2754901298.7012987
Net tangible assets: 1082280505194.8052
Owner earnings: 43075438961.03896
Return on net tangible assets (%): 3.9800623548407716
Buffett classification: The Gruesome
Stock price: 0.22038961038961036
P/E ratio: 0.0019318574572082965
Shares outstanding: 1466921000
Book value: 1147545625974.0254
P/B ratio: 0.00028172661752592947
Market cap (USD): 323294147.6623376
Debt to equity: 0.44846981790833534
Effective tax rate (%): 13.581134620596073
COGS to revenue (%): 0
SG&A to revenue (%): 7.847304322218002
Free cash flow (dilution-adjusted): -39126970129.87013
Buyback yield (%): 0
Retained earnings: 396867983116.8831
Receivables turnover: 0.41736016184309066
Capitalized R&D asset: 0
FCF margin (%): -25.924543952354647
Revenue growth (%): 111.8282518050095
Rule of 40 score: 85.90370785265486
Financial ratios for CFHS.L — quarterly report dated 2025-06-30
Total revenue: 36162978082.19178
Net income: 19157539726.027397
Capital expenditures: 1516701369.8630137
Operating cash flow: 317378257534.2466
Depreciation & amortization: 2912768493.150685
Net tangible assets: 1003538171232.8767
Owner earnings: 20553606849.315067
Return on net tangible assets (%): 2.048114106518175
Buffett classification: The Gruesome
Stock price: 0.2478082191780822
P/E ratio: 0.005131836371116173
Shares outstanding: 1466921000
Book value: 1070372131506.8477
P/B ratio: 0.0003396156065584243
Market cap (USD): 363515080.6849315
Debt to equity: 0.5518672243724192
Effective tax rate (%): 13.629332816983048
COGS to revenue (%): 0
SG&A to revenue (%): 37.040466042354524
Free cash flow (dilution-adjusted): 315646138356.16437
Buyback yield (%): 0
Retained earnings: 84916450684.9315
Receivables turnover: 0.09142341166271592
Capitalized R&D asset: 0
FCF margin (%): 872.8433195926477
Revenue growth (%): -76.0393224512902
Rule of 40 score: 796.8039971413575
Financial ratios for CFHS.L — quarterly report dated 2025-09-30
Total revenue: 158551962162.16217
Net income: 39176778378.37838
Capital expenditures: 1310036486.4864864
Operating cash flow: 63364808108.10811
Depreciation & amortization: 2925302702.7027025
Net tangible assets: 1162309104054.054
Owner earnings: 40792044594.5946
Return on net tangible assets (%): 3.5095693952937954
Buffett classification: The Gruesome
Stock price: 0.24445945945945946
P/E ratio: 0.0032596672660667176
Shares outstanding: 1466921000
Book value: 1226886764864.8633
P/B ratio: 0.00029228672522947006
Market cap (USD): 358602714.7297297
Debt to equity: 0.4908160966585211
Effective tax rate (%): 0.22211741843232813
COGS to revenue (%): 0
SG&A to revenue (%): 8.605759155503048
Free cash flow (dilution-adjusted): 61802101351.35135
Buyback yield (%): 0
Retained earnings: 127089985135.13513
Receivables turnover: 0.356184849461601
Capitalized R&D asset: 0
FCF margin (%): 38.97908326617997
Revenue growth (%): 338.4372376683215
Rule of 40 score: 377.4163209345014
Financial ratios for CNI.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.5789473684210527
Shares outstanding: 1001393894
Market cap (USD): 1581148253.6842105
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNI.AX — annual report dated 2022-06-30
Total revenue: 168450344.8275862
Gross profit: 156004827.5862069
Operating income: 78701379.31034483
Net income: -25766206.896551725
Capital expenditures: 1860000
Depreciation & amortization: 2882068.9655172415
Net tangible assets: 414902758.6206897
Owner earnings: -24744137.931034483
Return on net tangible assets (%): -5.963840301591232
Capex to operating income (%): 2.3633639159809667
Buffett classification: The Great
Stock price: 0.9862068965517241
Shares outstanding: 1001393894
Book value: 988414482.7586207
P/B ratio: 0.9991573187710586
Market cap (USD): 987581564.4275862
Debt to equity: 0.4527124946186892
Current ratio: 9.250400767182894
Quick ratio: 9.250400767182894
Interest coverage ratio: 3.738599135106801
COGS to revenue (%): 7.388240881381192
SG&A to revenue (%): 30.873725194777546
Free cash flow (dilution-adjusted): 116485517.24137932
Buyback yield (%): 0.022905135605972588
Retained earnings: -19982068.96551724
Receivables turnover: 2.1522553243983893
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.46621251934353
FCF margin (%): 69.15124890994174
Rule of 40 score: 69.15124890994174
Financial ratios for CNI.AX — annual report dated 2023-06-30
Total revenue: 205368874.17218542
Gross profit: 143312582.78145695
Operating income: 69990728.4768212
Net income: 70153642.38410597
Capital expenditures: 19466225.165562913
Depreciation & amortization: 3705960.264900662
Net tangible assets: 411484768.2119205
Owner earnings: 54393377.48344372
Return on net tangible assets (%): 13.218807033807472
Capex to operating income (%): 27.812576878678346
Buffett classification: The Good
Stock price: 0.9271523178807947
P/E ratio: 13.234447113242457
Shares outstanding: 1001393894
Book value: 938933112.5827816
P/B ratio: 0.9888294038111451
Market cap (USD): 928444669.9337748
Debt to equity: 0.2898470787966333
Current ratio: 14.271879476213213
Quick ratio: 13.370714263945468
Effective tax rate (%): 16.41324674709823
Interest coverage ratio: 2.86218009478673
COGS to revenue (%): 30.216989619711903
SG&A to revenue (%): 25.69177735426804
Free cash flow (dilution-adjusted): 73753642.38410597
Buyback yield (%): 0.000499304023118
Retained earnings: -16714569.536423841
Inventory turnover: 1.0563308833476124
Receivables turnover: 2.3267681087651377
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.736255979923143
FCF margin (%): 35.91276559381117
Revenue growth (%): 21.91656501646607
Rule of 40 score: 57.82933061027724
Financial ratios for CNI.AX — annual report dated 2024-06-30
Total revenue: 212480000
Gross profit: 185992666.66666666
Operating income: 102130000
Net income: 68107333.33333333
Capital expenditures: 7037333.333333333
Depreciation & amortization: 4410000
Net tangible assets: 275582000
Owner earnings: 65479999.99999999
Return on net tangible assets (%): 23.7606229724728
Capex to operating income (%): 6.890564313456705
Buffett classification: The Great
Stock price: 0.9866666666666667
P/E ratio: 14.507130540225722
Shares outstanding: 1001393894
Book value: 986353333.3333333
P/B ratio: 1.0017120052449089
Market cap (USD): 988041975.4133334
Debt to equity: 0.8582570140517597
Current ratio: 18.05817869801607
Quick ratio: 17.37553527609822
Effective tax rate (%): 6.617001828153565
Interest coverage ratio: 2.5303085359408035
COGS to revenue (%): 12.465800702811244
SG&A to revenue (%): 28.674071285140563
Free cash flow (dilution-adjusted): 104054666.66666667
Buyback yield (%): 0.010863236178648376
Retained earnings: -5082666.666666667
Inventory turnover: 0.46672618558154283
Receivables turnover: 2.6988441508954657
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.666999338312441
FCF margin (%): 48.97151104417671
Revenue growth (%): 3.4626112922313963
Rule of 40 score: 52.4341223364081
Financial ratios for CNXC — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 151.94
Shares outstanding: 61018350
Market cap (USD): 9271128099
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNXC — annual report dated 2022-11-30
Total revenue: 6324473000
Gross profit: 2257263000
Operating income: 640192000
Net income: 435640000
Capital expenditures: 140018000
Operating cash flow: 600720000
Depreciation & amortization: 309537000
Net tangible assets: -1194070000
Owner earnings: 605159000
Return on net tangible assets (%): -50.68036212282362
Capex to operating income (%): 21.871251124662603
Buffett classification: The Great
Stock price: 112.82
P/E ratio: 15.802245539895326
Shares outstanding: 61018350
Book value: 2695904000
P/B ratio: 2.5535368644432443
Market cap (USD): 6884090247
Debt to equity: 0.825062020012582
Current ratio: 1.5495948761751153
Quick ratio: 1.5495948761751153
Effective tax rate (%): 27.99374548555957
Interest coverage ratio: 9.13568126034591
COGS to revenue (%): 64.30907365720432
SG&A to revenue (%): 25.568470289935618
Free cash flow (dilution-adjusted): 413560000
Buyback yield (%): 1.9362471324092159
Retained earnings: 774114000
Receivables turnover: 4.548429528347887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.560726626571403
FCF margin (%): 6.539042857800167
Rule of 40 score: 6.539042857800167
Financial ratios for CNXC — annual report dated 2023-11-30
Total revenue: 7114706000
Gross profit: 2577935000
Operating income: 661327000
Net income: 313842000
Capital expenditures: 180532000
Operating cash flow: 678008000
Depreciation & amortization: 388295000
Net tangible assets: -3740339000
Owner earnings: 521605000
Return on net tangible assets (%): -13.94539371966017
Capex to operating income (%): 27.29844691052989
Buffett classification: The Good
Stock price: 87.69
P/E ratio: 17.049021837421378
Shares outstanding: 61018350
Book value: 4143294000
P/B ratio: 1.2914118842399307
Market cap (USD): 5350699111.5
Debt to equity: 1.1927768099487992
Current ratio: 1.3783005044746024
Quick ratio: 1.3783005044746024
Effective tax rate (%): 23.12090302478027
Interest coverage ratio: 3.2901186046048836
COGS to revenue (%): 63.76610642800982
SG&A to revenue (%): 26.938681654589804
Free cash flow (dilution-adjusted): 435363000
Buyback yield (%): 1.517353121679079
Retained earnings: 1024461000
Receivables turnover: 3.766606843172445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.348055844484453
FCF margin (%): 6.1191987413113065
Revenue growth (%): 12.494843443872714
Rule of 40 score: 18.61404218518402
Financial ratios for CNXC — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 71.13
Shares outstanding: 61018350
Market cap (USD): 4340235235.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNXC — annual report dated 2024-11-30
Total revenue: 9618900000
Gross profit: 3448887000
Operating income: 596387000
Net income: 251217000
Capital expenditures: 238762000
Operating cash flow: 667492000
Depreciation & amortization: 705845000
Net tangible assets: -3234183000
Owner earnings: 718300000
Return on net tangible assets (%): -22.209627593738514
Capex to operating income (%): 40.03474254133641
Buffett classification: The Good
Stock price: 42.81
P/E ratio: 10.398163991688461
Shares outstanding: 61018350
Book value: 4039724000
P/B ratio: 0.6466272357963069
Market cap (USD): 2612195563.5
Debt to equity: 1.1722528568783412
Current ratio: 1.4241935491952402
Quick ratio: 1.4241935491952402
Effective tax rate (%): 16.05786002125143
Interest coverage ratio: 1.8531234075344594
COGS to revenue (%): 64.14468390356485
SG&A to revenue (%): 29.65515807420807
Free cash flow (dilution-adjusted): 332673000
Buyback yield (%): 5.722427604145955
Retained earnings: 1191871000
Receivables turnover: 4.992326404693531
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.966480335146627
FCF margin (%): 3.4585347596918568
Revenue growth (%): 35.19743472182828
Rule of 40 score: 38.65596948152014
Financial ratios for CNXC — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 42.81
Shares outstanding: 61018350
Market cap (USD): 2612195563.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNXC — quarterly report dated 2025-02-28
Total revenue: 2372222000
Gross profit: 855899000
Operating income: 168867000
Net income: 70257000
Capital expenditures: 50618000
Operating cash flow: 1408000
Depreciation & amortization: 160716000
Net tangible assets: -3063060000
Owner earnings: 180355000
Return on net tangible assets (%): -5.888066182183829
Capex to operating income (%): 29.975069137250028
Buffett classification: The Good
Stock price: 43.28
P/E ratio: 9.397192407873948
Shares outstanding: 61018350
Book value: 4033770000
P/B ratio: 0.6546913155683145
Market cap (USD): 2640874188
Debt to equity: 1.215213559523721
Current ratio: 1.6519497997973422
Quick ratio: 1.6519497997973422
Effective tax rate (%): 30.29506310024605
Interest coverage ratio: 2.313436720826369
COGS to revenue (%): 63.91994509788713
SG&A to revenue (%): 28.96153901279054
Free cash flow (dilution-adjusted): -75696000
Buyback yield (%): 1.057415007761059
Retained earnings: 1239638000
Receivables turnover: 1.177385981186418
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.671464777314711
FCF margin (%): -3.190932383225516
Rule of 40 score: -3.190932383225516
Financial ratios for CNXC — quarterly report dated 2025-05-31
Total revenue: 2417371000
Gross profit: 848148000
Operating income: 148345000
Net income: 42093000
Capital expenditures: 55792000
Operating cash flow: 236536000
Depreciation & amortization: 165309000
Net tangible assets: -3009235000
Owner earnings: 151610000
Return on net tangible assets (%): -5.0381575383776935
Capex to operating income (%): 37.60962620917456
Buffett classification: The Good
Stock price: 53.99
P/E ratio: 29.32248078771696
Shares outstanding: 61018350
Book value: 4278700000
P/B ratio: 0.7699489836866338
Market cap (USD): 3294380716.5
Debt to equity: 1.143047187229766
Current ratio: 1.606732155480613
Quick ratio: 1.606732155480613
Effective tax rate (%): 18.615262659267994
Interest coverage ratio: 1.9672837705222397
COGS to revenue (%): 64.9144463137847
SG&A to revenue (%): 28.94892840197057
Free cash flow (dilution-adjusted): 154084000
Buyback yield (%): 1.4212079303858443
Retained earnings: 1259559000
Receivables turnover: 1.1726772716953233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4232883145865824
FCF margin (%): 6.374031954548971
Revenue growth (%): 1.9032367122469986
Rule of 40 score: 8.277268666795969
Financial ratios for CNXC — quarterly report dated 2025-08-31
Total revenue: 2483253000
Gross profit: 855007000
Operating income: 146984000
Net income: 88110000
Capital expenditures: 65054000
Operating cash flow: 224803000
Depreciation & amortization: 168557000
Net tangible assets: -2926714000
Owner earnings: 191613000
Return on net tangible assets (%): -6.547035344075301
Capex to operating income (%): 44.259239100854515
Buffett classification: The Good
Stock price: 51.18
P/E ratio: 15.578764606405269
Shares outstanding: 61018350
Book value: 4344129000
P/B ratio: 0.7188826927100922
Market cap (USD): 3122919153
Debt to equity: 1.1113373935258368
Current ratio: 1.5615854802673526
Quick ratio: 1.5615854802673526
Effective tax rate (%): 20.93787014105739
Interest coverage ratio: 2.041047574082817
COGS to revenue (%): 65.56907411367267
SG&A to revenue (%): 28.51191562035765
Free cash flow (dilution-adjusted): 134982000
Buyback yield (%): 1.337594665551049
Retained earnings: 1325693000
Receivables turnover: 1.2102094623572068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4131832234776245
FCF margin (%): 5.435692617707499
Revenue growth (%): 2.7253574234157685
Rule of 40 score: 8.161050041123268
Financial ratios for CNXC — quarterly report dated 2025-11-30
Total revenue: 2552925000
Gross profit: 875957000
Operating income: 145347000
Net income: -1479384000
Capital expenditures: 63032000
Operating cash flow: 344220000
Depreciation & amortization: 165851000
Net tangible assets: -2887739000
Owner earnings: -1376565000
Capex to operating income (%): 43.3665641533709
Buffett classification: The Good
Stock price: 35.39
Shares outstanding: 61018350
Book value: 2744345000
P/B ratio: 0.7868687816218443
Market cap (USD): 2159439406.5
Debt to equity: 1.6902080460000473
Current ratio: 1.404376806975209
Quick ratio: 1.404376806975209
Interest coverage ratio: 2.078315578751698
COGS to revenue (%): 65.68810286240293
SG&A to revenue (%): 28.618545394008834
Free cash flow (dilution-adjusted): 262715000
Buyback yield (%): 3.343275101060355
Retained earnings: -177010000
Receivables turnover: 1.2770876343970374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.697040048870158
FCF margin (%): 10.290744929835386
Revenue growth (%): 2.8056746533679813
Rule of 40 score: 13.096419583203367
Financial ratios for CNXC — annual report dated 2025-11-30
Total revenue: 9825771000
Gross profit: 3435011000
Operating income: 609543000
Net income: -1278924000
Capital expenditures: 234496000
Operating cash flow: 806967000
Depreciation & amortization: 660433000
Net tangible assets: -2887739000
Owner earnings: -852987000
Capex to operating income (%): 38.47078877125978
Buffett classification: The Good
Stock price: 35.39
Shares outstanding: 61018350
Book value: 2744345000
P/B ratio: 0.7868687816218443
Market cap (USD): 2159439406.5
Debt to equity: 1.6902080460000473
Current ratio: 1.404376806975209
Quick ratio: 1.404376806975209
Interest coverage ratio: 2.099345959517684
COGS to revenue (%): 65.0407993428709
SG&A to revenue (%): 28.755687467171786
Free cash flow (dilution-adjusted): 476085000
Buyback yield (%): 8.73898102590729
Retained earnings: -177010000
Receivables turnover: 4.915291535206483
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.1168918691714484
FCF margin (%): 4.845268630828055
Revenue growth (%): 2.150672114275021
Rule of 40 score: 6.995940745103075
Financial ratios for CRDA.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2116216216216216
Shares outstanding: 139354139
Market cap (USD): 168844487.87486485
Buyback yield (%): 1.9208463859636906
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRDA.L — annual report dated 2022-12-31
Total revenue: 2517228915.6626506
Gross profit: 1187469879.5180724
Operating income: 535783132.5301205
Net income: 787108433.7349398
Capital expenditures: 168072289.15662652
Operating cash flow: 371325301.2048193
Depreciation & amortization: 145421686.74698797
Net tangible assets: 1400481927.7108433
Owner earnings: 764457831.3253012
Return on net tangible assets (%): 54.58534067446662
Capex to operating income (%): 31.36946255902856
Buffett classification: The Good
Stock price: 0.7153012048192772
P/E ratio: 0.12664098013822134
Shares outstanding: 139354139
Book value: 2929036144.578314
P/B ratio: 0.03403173556180329
Market cap (USD): 99680183.52325302
Debt to equity: 0.253300974867344
Current ratio: 2.378843788437884
Quick ratio: 1.4276342763427632
Effective tax rate (%): 16.24358974358974
Interest coverage ratio: 17.30350194552529
COGS to revenue (%): 52.82630546115925
SG&A to revenue (%): 25.88905375005983
Free cash flow (dilution-adjusted): 200963855.42168677
Buyback yield (%): 0
Retained earnings: 1982771084.3373494
Inventory turnover: 2.3786637931034487
Receivables turnover: 6.64113159567705
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.23449953586633
FCF margin (%): 7.983535155315178
Rule of 40 score: 7.983535155315178
Financial ratios for CRDA.L — annual report dated 2023-12-31
Total revenue: 2144936708.8607595
Gross profit: 924050632.9113923
Operating income: 313291139.2405063
Net income: 217848101.26582277
Capital expenditures: 223291139.24050632
Operating cash flow: 427215189.8734177
Depreciation & amortization: 159746835.44303796
Net tangible assets: 1194936708.8607595
Owner earnings: 154303797.46835443
Return on net tangible assets (%): 12.91313559322034
Capex to operating income (%): 71.27272727272728
Buffett classification: The Good
Stock price: 0.5846835443037974
P/E ratio: 0.3740132295415456
Shares outstanding: 139354139
Book value: 2997594936.7088604
P/B ratio: 0.027181148095139565
Market cap (USD): 81478071.90392405
Debt to equity: 0.29986064777669863
Current ratio: 2.840099937539038
Quick ratio: 1.7745159275452844
Effective tax rate (%): 27.1688531527719
Interest coverage ratio: 9.555984555984555
COGS to revenue (%): 56.919445264089696
SG&A to revenue (%): 28.474476246680435
Free cash flow (dilution-adjusted): 193291139.2405063
Buyback yield (%): 0
Retained earnings: 2075949367.0886075
Inventory turnover: 2.8267878077373974
Receivables turnover: 5.328616352201258
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.594354096348573
FCF margin (%): 9.011507819415755
Revenue growth (%): -14.789763635934024
Rule of 40 score: -5.77825581651827
Financial ratios for CRDA.L — annual report dated 2024-12-31
Total revenue: 2035125000
Gross profit: 917375000
Operating income: 303125000
Net income: 199500000
Capital expenditures: 221875000
Operating cash flow: 399250000
Depreciation & amortization: 169750000
Net tangible assets: 1214875000
Owner earnings: 147375000
Return on net tangible assets (%): 12.130877662310938
Capex to operating income (%): 73.19587628865979
Buffett classification: The Good
Stock price: 0.39674999999999994
P/E ratio: 0.27713661477819546
Shares outstanding: 139354139
Book value: 2871125000
P/B ratio: 0.019256826034481252
Market cap (USD): 55288754.64824999
Debt to equity: 0.30436675519178025
Current ratio: 2.627637444279346
Quick ratio: 1.5343239227340268
Effective tax rate (%): 23.195380173243503
Interest coverage ratio: 7.84789644012945
COGS to revenue (%): 54.92291628278362
SG&A to revenue (%): 31.10374055647688
Free cash flow (dilution-adjusted): 165750000
Buyback yield (%): 0
Retained earnings: 2075125000
Inventory turnover: 2.430551780375102
Receivables turnover: 5.879739978331528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.64309127584468
FCF margin (%): 8.144462870831031
Revenue growth (%): -5.119578046621422
Rule of 40 score: 3.024884824209609
Financial ratios for CRDA.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1214875000
Buffett classification: The Gruesome
Stock price: 0.39674999999999994
Shares outstanding: 139354139
Book value: 2871125000
P/B ratio: 0.019256826034481252
Market cap (USD): 55288754.64824999
Debt to equity: 0.30436675519178025
Current ratio: 2.627637444279346
Quick ratio: 1.5343239227340268
Buyback yield (%): 0
Retained earnings: 2075125000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRDA.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1259589041.0958905
Buffett classification: The Gruesome
Stock price: 0.38465753424657534
Shares outstanding: 139354139
Book value: 3056438356.1643834
P/B ratio: 0.017537935743635713
Market cap (USD): 53603619.49479452
Debt to equity: 0.33071889566152746
Current ratio: 2.069313593539704
Quick ratio: 1.1908927770300581
Buyback yield (%): 0
Retained earnings: 2235479452.054795
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVSA — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.64
Shares outstanding: 34030887
Market cap (USD): 1212860812.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVSA — annual report dated 2022-06-30
Total revenue: 1381842000
Gross profit: 722066000
Operating income: 155572000
Net income: 310991000
Capital expenditures: 31054000
Operating cash flow: 10601000
Depreciation & amortization: 186596000
Net tangible assets: -343453000
Owner earnings: 466533000
Return on net tangible assets (%): -135.83605325910676
Capex to operating income (%): 19.96117553287224
Buffett classification: The Great
Stock price: 35.97
P/E ratio: 3.936097846529321
Shares outstanding: 34030887
Book value: 1491386000
P/B ratio: 0.8207741023383617
Market cap (USD): 1224091005.3899999
Debt to equity: 0.7152635199740376
Current ratio: 1.315019343934927
Quick ratio: 1.315019343934927
Interest coverage ratio: 1.572387305437639
COGS to revenue (%): 47.746124376014045
SG&A to revenue (%): 40.995569681627856
Free cash flow (dilution-adjusted): -43064000
Buyback yield (%): 9.803192693321652
Retained earnings: 2310396000
Receivables turnover: 16.927077846511914
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.968403966403654
FCF margin (%): -3.116419966971622
Rule of 40 score: -3.116419966971622
Financial ratios for CVSA — annual report dated 2023-06-30
Total revenue: 1450826000
Gross profit: 802340000
Operating income: 216331000
Net income: 93358000
Capital expenditures: 26014000
Operating cash flow: 191914000
Depreciation & amortization: 151085000
Net tangible assets: -316264000
Owner earnings: 218429000
Return on net tangible assets (%): -69.0654010573445
Capex to operating income (%): 12.025091179719965
Buffett classification: The Great
Stock price: 34.34
P/E ratio: 12.51762740825639
Shares outstanding: 34030887
Book value: 1457336000
P/B ratio: 0.8018882807945458
Market cap (USD): 1168620659.5800002
Debt to equity: 0.6149515279935444
Current ratio: 1.1138535678091293
Quick ratio: 1.1138535678091293
Effective tax rate (%): 9.178381755701343
Interest coverage ratio: 3.7140919548123477
COGS to revenue (%): 44.69771013202134
SG&A to revenue (%): 40.3914046205403
Free cash flow (dilution-adjusted): 151601000
Buyback yield (%): 10.536609890522879
Retained earnings: 2403750000
Receivables turnover: 14.120098492442748
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.092066784962876
FCF margin (%): 10.449288887847336
Revenue growth (%): 4.992177108526156
Rule of 40 score: 15.441465996373491
Financial ratios for CVSA — annual report dated 2024-06-30
Total revenue: 1584652000
Gross profit: 886104000
Operating income: 253139000
Net income: 136777000
Capital expenditures: 48893000
Operating cash flow: 295775000
Depreciation & amortization: 107961000
Net tangible assets: -368821000
Owner earnings: 195845000
Return on net tangible assets (%): -53.100284419813406
Capex to operating income (%): 19.31468481743232
Buffett classification: The Great
Stock price: 68.21
P/E ratio: 16.97103169589916
Shares outstanding: 34030887
Book value: 1369135000
P/B ratio: 1.6954111919350536
Market cap (USD): 2321246802.27
Debt to equity: 0.6192617966818466
Current ratio: 0.8573341508478295
Quick ratio: 0.8573341508478295
Effective tax rate (%): 15.99638885669495
Interest coverage ratio: 4.665382701487311
COGS to revenue (%): 44.08210761731913
SG&A to revenue (%): 39.94347023826052
Free cash flow (dilution-adjusted): 220935000
Buyback yield (%): 11.285572897453967
Retained earnings: 2540509000
Receivables turnover: 12.494003926422934
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.231852548629846
FCF margin (%): 13.94217784093921
Revenue growth (%): 9.22412473997571
Rule of 40 score: 23.166302580914923
Financial ratios for CVSA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.48
Shares outstanding: 34030887
Market cap (USD): 2568651350.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVSA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 90.85
Shares outstanding: 34030887
Market cap (USD): 3091706083.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVSA — quarterly report dated 2025-03-31
Total revenue: 466055000
Gross profit: 266186000
Operating income: 91019000
Net income: 60832000
Capital expenditures: 10243000
Operating cash flow: 207910000
Depreciation & amortization: 24317000
Net tangible assets: -296828000
Owner earnings: 74906000
Return on net tangible assets (%): -25.235489913350495
Capex to operating income (%): 11.253694283611114
Buffett classification: The Great
Stock price: 100.64
P/E ratio: 14.075110417543398
Shares outstanding: 34030887
Book value: 1432713000
P/B ratio: 2.390477693494789
Market cap (USD): 3424868467.68
Debt to equity: 0.5447901987348478
Current ratio: 0.8330906877752886
Quick ratio: 0.8330906877752886
Effective tax rate (%): 23.36858558229236
Interest coverage ratio: 8.006597466572837
COGS to revenue (%): 42.88528178004742
SG&A to revenue (%): 37.58504897490639
Free cash flow (dilution-adjusted): 187404000
Buyback yield (%): 2.1130738503666775
Retained earnings: 2723362000
Receivables turnover: 2.8597243698304005
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.046745717347134
FCF margin (%): 40.21070474514811
Rule of 40 score: 40.21070474514811
Financial ratios for CVSA — quarterly report dated 2025-06-30
Total revenue: 457106000
Gross profit: 258176000
Operating income: 77313000
Net income: 54212000
Capital expenditures: 18990000
Operating cash flow: 59692000
Depreciation & amortization: 20453000
Net tangible assets: -293111000
Owner earnings: 55675000
Return on net tangible assets (%): -18.9945106120207
Capex to operating income (%): 24.562492724380117
Buffett classification: The Great
Stock price: 127.23
P/E ratio: 37.63559814514446
Shares outstanding: 34030887
Book value: 1433625000
P/B ratio: 3.0201410780434217
Market cap (USD): 4329749753.01
Debt to equity: 0.5398901386345801
Current ratio: 0.8193894004453396
Quick ratio: 0.8193894004453396
Effective tax rate (%): 20.589650496478722
Interest coverage ratio: 8.314119797827724
COGS to revenue (%): 43.51944625535434
SG&A to revenue (%): 39.56697133706405
Free cash flow (dilution-adjusted): 30293000
Buyback yield (%): 1.5402506796989468
Retained earnings: 2777574000
Receivables turnover: 3.1268152870599017
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.444668456286131
FCF margin (%): 6.627128062200015
Revenue growth (%): -1.9201596378109878
Rule of 40 score: 4.706968424389027
Financial ratios for CVSA — annual report dated 2025-06-30
Total revenue: 1788290000
Gross profit: 1016860000
Operating income: 344856000
Net income: 237065000
Capital expenditures: 50327000
Operating cash flow: 337899000
Depreciation & amortization: 84465000
Net tangible assets: -293111000
Owner earnings: 271203000
Return on net tangible assets (%): -92.52569845553391
Capex to operating income (%): 14.59362748509523
Buffett classification: The Great
Stock price: 127.23
P/E ratio: 18.263977191951575
Shares outstanding: 34030887
Book value: 1433625000
P/B ratio: 3.0201410780434217
Market cap (USD): 4329749753.01
Debt to equity: 0.5398901386345801
Current ratio: 0.8193894004453396
Quick ratio: 0.8193894004453396
Effective tax rate (%): 22.054911997427258
Interest coverage ratio: 7.779116194085403
COGS to revenue (%): 43.1378579536876
SG&A to revenue (%): 37.578021461843434
Free cash flow (dilution-adjusted): 245982000
Buyback yield (%): 4.92233990779346
Retained earnings: 2777574000
Receivables turnover: 12.232726128504881
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.36500439979059
FCF margin (%): 13.75515156937633
Revenue growth (%): 12.850644810343217
Rule of 40 score: 26.60579637971955
Financial ratios for CVSA — quarterly report dated 2025-09-30
Total revenue: 462288000
Gross profit: 261521000
Operating income: 85787000
Net income: 61832000
Capital expenditures: 16023000
Operating cash flow: 130549000
Depreciation & amortization: 20317000
Net tangible assets: -266307000
Owner earnings: 66126000
Return on net tangible assets (%): -24.83074046119704
Capex to operating income (%): 18.677655122571018
Buffett classification: The Great
Stock price: 154.45
P/E ratio: 29.71613162413216
Shares outstanding: 34030887
Book value: 1457624000
P/B ratio: 3.6059165444243506
Market cap (USD): 5256070497.15
Debt to equity: 0.5323389296553844
Current ratio: 0.9836997239063779
Quick ratio: 0.9836997239063779
Effective tax rate (%): 20.567689565907404
Interest coverage ratio: 9.012186154007773
COGS to revenue (%): 43.42898799017063
SG&A to revenue (%): 38.0139653203198
Free cash flow (dilution-adjusted): 106233000
Buyback yield (%): 0.1444995839404787
Retained earnings: 2839406000
Receivables turnover: 2.3726910186463557
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7447721301335273
FCF margin (%): 22.979830754854117
Revenue growth (%): 1.1336539008457558
Rule of 40 score: 24.11348465569987